APA (7th ed.) Citation

HJ, J., G, U., AD, Ø., AV, N., HJ, K., SA, N., . . . PA, J. (2026). Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS. Blood neoplasia, 3(3), 100243. https://doi.org/10.1016/j.bneo.2026.100243

Chicago Style (17th ed.) Citation

HJ, Jang, et al. "Bone Marrow Immunosuppressive States Associate with Survival After Guadecitabine and Atezolizumab Therapy in HMA-R/R MDS." Blood Neoplasia 3, no. 3 (2026): 100243. https://doi.org/10.1016/j.bneo.2026.100243.

MLA (9th ed.) Citation

HJ, Jang, et al. "Bone Marrow Immunosuppressive States Associate with Survival After Guadecitabine and Atezolizumab Therapy in HMA-R/R MDS." Blood Neoplasia, vol. 3, no. 3, 2026, p. 100243, https://doi.org/10.1016/j.bneo.2026.100243.